Host and microbial cells as targets for armed antibodies in the treatment of infectious diseases

E. Dadachova, A. Casadevall

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

There is a renewed interest in antibody-based therapy for infectious diseases. Antibodies armed with different cytotoxic agents such as toxins, drugs or radionuclides can specifically target virally infected host cells or microbes themselves, thus potentially providing new options for the treatment of infectious diseases. The technologies for arming antibodies with different cytotoxic agents are well advanced. Overall, armed antibody therapy provides an exciting new strategy that may potentially be useful against a variety of infectious diseases and tumors caused by microbial agents. This review highlights the use of armed antibodies to target infected host cells or to target the microbes themselves, describing challenges and future directions for both approaches.

Original languageEnglish (US)
Pages (from-to)184-188
Number of pages5
JournalCurrent Opinion in Investigational Drugs
Volume9
Issue number2
StatePublished - Feb 2008

Fingerprint

Communicable Diseases
Antibodies
Cytotoxins
Radioisotopes
Technology
Therapeutics
Pharmaceutical Preparations
Neoplasms

Keywords

  • Immunotoxin
  • Monoclonal antibodies
  • Radioimmunotherapy
  • Safety
  • Viral cancers

ASJC Scopus subject areas

  • Pharmacology

Cite this

Host and microbial cells as targets for armed antibodies in the treatment of infectious diseases. / Dadachova, E.; Casadevall, A.

In: Current Opinion in Investigational Drugs, Vol. 9, No. 2, 02.2008, p. 184-188.

Research output: Contribution to journalArticle

@article{8dd232491fe441ef8a5b859e64e48e6e,
title = "Host and microbial cells as targets for armed antibodies in the treatment of infectious diseases",
abstract = "There is a renewed interest in antibody-based therapy for infectious diseases. Antibodies armed with different cytotoxic agents such as toxins, drugs or radionuclides can specifically target virally infected host cells or microbes themselves, thus potentially providing new options for the treatment of infectious diseases. The technologies for arming antibodies with different cytotoxic agents are well advanced. Overall, armed antibody therapy provides an exciting new strategy that may potentially be useful against a variety of infectious diseases and tumors caused by microbial agents. This review highlights the use of armed antibodies to target infected host cells or to target the microbes themselves, describing challenges and future directions for both approaches.",
keywords = "Immunotoxin, Monoclonal antibodies, Radioimmunotherapy, Safety, Viral cancers",
author = "E. Dadachova and A. Casadevall",
year = "2008",
month = "2",
language = "English (US)",
volume = "9",
pages = "184--188",
journal = "Current Opinion in Investigational Drugs",
issn = "1354-3784",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Host and microbial cells as targets for armed antibodies in the treatment of infectious diseases

AU - Dadachova, E.

AU - Casadevall, A.

PY - 2008/2

Y1 - 2008/2

N2 - There is a renewed interest in antibody-based therapy for infectious diseases. Antibodies armed with different cytotoxic agents such as toxins, drugs or radionuclides can specifically target virally infected host cells or microbes themselves, thus potentially providing new options for the treatment of infectious diseases. The technologies for arming antibodies with different cytotoxic agents are well advanced. Overall, armed antibody therapy provides an exciting new strategy that may potentially be useful against a variety of infectious diseases and tumors caused by microbial agents. This review highlights the use of armed antibodies to target infected host cells or to target the microbes themselves, describing challenges and future directions for both approaches.

AB - There is a renewed interest in antibody-based therapy for infectious diseases. Antibodies armed with different cytotoxic agents such as toxins, drugs or radionuclides can specifically target virally infected host cells or microbes themselves, thus potentially providing new options for the treatment of infectious diseases. The technologies for arming antibodies with different cytotoxic agents are well advanced. Overall, armed antibody therapy provides an exciting new strategy that may potentially be useful against a variety of infectious diseases and tumors caused by microbial agents. This review highlights the use of armed antibodies to target infected host cells or to target the microbes themselves, describing challenges and future directions for both approaches.

KW - Immunotoxin

KW - Monoclonal antibodies

KW - Radioimmunotherapy

KW - Safety

KW - Viral cancers

UR - http://www.scopus.com/inward/record.url?scp=38849103765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849103765&partnerID=8YFLogxK

M3 - Article

C2 - 18246521

AN - SCOPUS:38849103765

VL - 9

SP - 184

EP - 188

JO - Current Opinion in Investigational Drugs

JF - Current Opinion in Investigational Drugs

SN - 1354-3784

IS - 2

ER -